Adial Pharmaceuticals Inc (ADIL)
1.500
-0.05
(-3.25%)
USD |
NASDAQ |
May 20, 16:00
1.50
0.00 (0.00%)
After-Hours: 20:00
Adial Pharmaceuticals Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.35M |
| September 30, 2023 | 0.35M |
| June 30, 2023 | 0.80M |
| March 31, 2023 | |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | -0.0337M |
| March 31, 2021 | -0.0003M |
| December 31, 2020 | -0.35M |
| September 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.0235M |
| March 31, 2017 | 0.0117M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.35M
Minimum
Dec 2020
0.80M
Maximum
Jun 2023
0.0797M
Average
--
Median
Mar 2020
Cash from Investing (Quarterly) Benchmarks
| BioVie Inc | 0.00 |
| BioSig Technologies Inc | -0.004M |
| Precision BioSciences Inc | -0.026M |
| Humacyte Inc | -0.391M |
| Monogram Technologies Inc | -0.0114M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.626M |
| Cash from Financing (Quarterly) | 3.824M |
| Free Cash Flow | -6.134M |
| Free Cash Flow Per Share (Quarterly) | -0.5505 |
| Free Cash Flow Yield | -236.2% |